BioSpace News Archive

Business

ImaginAb Announces Immuno-Oncology License and Clinical Trial Collaboration with Nektar Therapeutics

Nektar will use ImaginAb’s CD8 ImmunoPET technology to accelerate the development of its investigational immuno-oncology medicines

January 3, 2019
·
3 min read
Business

Clinical Genomics Appoints Betsy Hanna CEO

Dr. Lawrence LaPointe Named Chief Innovation Officer

January 3, 2019
·
3 min read
Business

Tragara Pharmaceuticals Appoints Scott Megaffin as Chief Executive Officer and Changes Name to Adastra Pharmaceuticals

Company Well-Positioned for Next Phase of Clinical Advancement with Lead Oral Drug Candidate, TG02, for Treatment of Adult and Pediatric Brain Cancers

January 3, 2019
·
4 min read
Job Trends

Luster 365 Offers A Full Year of Professional Grade Teeth Whitening at Home

Make 2019 your brightest year with this 12-product, value-priced bundle

January 3, 2019
·
2 min read
Genetown

New Harvard Study Finds That Parental Warmth in Childhood is Associated with Subsequent Flourishing Across Multiple Domains

A childhood with loving parents can lead to life as an adult with flourishing in multiple domains, a new study from the Human Flourishing Program at Harvard University’s Institute for Quantitative Social Sciences has found.

January 3, 2019
·
2 min read
Business

Health Enterprise Partners Announces Partner Promotion

--Ezra Mehlman Promoted to Managing Partner--

January 3, 2019
·
2 min read
Business

Ablexis Announces Licensing Agreement with Corvidia Therapeutics

Ablexis grants rights to Corvidia to use the AlivaMab Mouse™ platform for research, development and potential commercialization of antibodies

January 3, 2019
·
1 min read
BioMidwest

Exicure to Present at Biotech Showcase 2019 on January 8th at 2:30 pm PT

Exicure, Inc. announced today that its CEO, Dr. David Giljohann, will present a corporate update on Tuesday, January 8, 2019 from 2:30 pm to 3:00 pm PT at the Biotech Showcase 2019.

January 3, 2019
·
3 min read
Biotech Beach

Thousand Oaks Biopharmaceuticals Completes $45 Million Series A Financing to Expand Integrated CMC and Build the World Largest Cell Cultural Production Facility in China

Thousand Oaks Biopharmaceuticals, Inc. today announced the closing of a $45 Million USD Series A financing to advance its phase II CDMO and started its construction of Large Scale Cell Culture Media (LSCCM) cGMP Manufacturing facilities based in Haimen, Nantong (part of greater Shanghai), China.

January 3, 2019
·
3 min read
Business

Fulcrum Therapeutics Appoints Biotech Executive Bryan Stuart as Chief Operating Officer

New COO brings extensive leadership and strategic expertise in rare disease

January 3, 2019
·
2 min read